» Articles » PMID: 26882543

NAT10 Regulates P53 Activation Through Acetylating P53 at K120 and Ubiquitinating Mdm2

Overview
Journal EMBO Rep
Specialty Molecular Biology
Date 2016 Feb 17
PMID 26882543
Citations 92
Authors
Affiliations
Soon will be listed here.
Abstract

As a genome guardian, p53 maintains genome stability by arresting cells for damage repair or inducing cell apoptosis to eliminate the damaged cells in stress response. Several nucleolar proteins stabilize p53 by interfering Mdm2-p53 interaction upon cellular stress, while other mechanisms by which nucleolar proteins activate p53 remain to be determined. Here, we identify NAT10 as a novel regulator for p53 activation. NAT10 acetylates p53 at K120 and stabilizes p53 by counteracting Mdm2 action. In addition, NAT10 promotes Mdm2 degradation with its intrinsic E3 ligase activity. After DNA damage, NAT10 translocates to nucleoplasm and activates p53-mediated cell cycle control and apoptosis. Finally, NAT10 inhibits cell proliferation and expression of NAT10 decreases in human colorectal carcinomas. Thus, our data demonstrate that NAT10 plays a critical role in p53 activation via acetylating p53 and counteracting Mdm2 action, providing a novel pathway by which nucleolar protein activates p53 as a cellular stress sensor.

Citing Articles

Biological function and mechanism of NAT10 in cancer.

Han Y, Zhang X, Miao L, Lin H, Zhuo Z, He J Cancer Innov. 2025; 4(1):e154.

PMID: 39817252 PMC: 11732740. DOI: 10.1002/cai2.154.


The role of acetylation and deacetylation in cancer metabolism.

Wang C, Ma X Clin Transl Med. 2025; 15(1):e70145.

PMID: 39778006 PMC: 11706801. DOI: 10.1002/ctm2.70145.


RNA N4-acetylcytidine modification and its role in health and diseases.

Wang Q, Yuan Y, Zhou Q, Jia Y, Liu J, Xiao G MedComm (2020). 2025; 6(1):e70015.

PMID: 39764566 PMC: 11702397. DOI: 10.1002/mco2.70015.


Advances of NAT10 in diseases: insights from dual properties as protein and RNA acetyltransferase.

Xiao B, Wu S, Tian Y, Huang W, Chen G, Luo D Cell Biol Toxicol. 2024; 41(1):17.

PMID: 39725720 PMC: 11671434. DOI: 10.1007/s10565-024-09962-6.


RNA modifications: emerging players in the regulation of reproduction and development.

Wen J, Zhu Q, Liu Y, Gou L Acta Biochim Biophys Sin (Shanghai). 2024; 57(1):33-58.

PMID: 39574165 PMC: 11802351. DOI: 10.3724/abbs.2024201.


References
1.
Linares L, Kiernan R, Triboulet R, Chable-Bessia C, Latreille D, Cuvier O . Intrinsic ubiquitination activity of PCAF controls the stability of the oncoprotein Hdm2. Nat Cell Biol. 2007; 9(3):331-8. DOI: 10.1038/ncb1545. View

2.
Yuan J, Luo K, Zhang L, Cheville J, Lou Z . USP10 regulates p53 localization and stability by deubiquitinating p53. Cell. 2010; 140(3):384-96. PMC: 2820153. DOI: 10.1016/j.cell.2009.12.032. View

3.
Kong R, Zhang L, Hu L, Peng Q, Han W, Du X . hALP, a novel transcriptional U three protein (t-UTP), activates RNA polymerase I transcription by binding and acetylating the upstream binding factor (UBF). J Biol Chem. 2010; 286(9):7139-48. PMC: 3044971. DOI: 10.1074/jbc.M110.173393. View

4.
Meng L, Lin T, Tsai R . Nucleoplasmic mobilization of nucleostemin stabilizes MDM2 and promotes G2-M progression and cell survival. J Cell Sci. 2008; 121(Pt 24):4037-46. PMC: 5048913. DOI: 10.1242/jcs.037952. View

5.
Xu C, Fan C, Wang X . Regulation of Mdm2 protein stability and the p53 response by NEDD4-1 E3 ligase. Oncogene. 2014; 34(3):281-9. DOI: 10.1038/onc.2013.557. View